BEZAFIBRAT (Bezafibrate).

     2 - (? para-Hlorbenzoilaminoetil) fenoksi-2- methyl-propionic acid.

     Synonyms : Bezalip, Bezamidin, Holestenorm, Bezalip, Bezalin, Bezamidin, Bezifol, Cedur, Cholestenorm, Difaterol, Oralipin and others.

     As of close to gemfibrozilu.

     When applied Moyle (mostly with gipertriglitseridemiey types IV and V) with the ineffectiveness of diet and high risk of relapse as well as Moyle type IIb (including diabetes).

     As published in foreign medical literature indicates that the application bezafibrata in patients with post-myocardial infarction with NCEP and gipertriglitseridemiey, slowing the progression of coronary atherosclerosis, reduced the incidence of worsening coronary blood flow in the high-risk groups, improving lipid profile and reduces fibrinogena in plasma.

     Assign the interior of 0.2 g three times a day, retardnye form of 0.4-1 g once a day.

     Possible side effects : neuralgia, cholestasis, myo with pain and rigidity of muscles, rabdomioliz, Alopecia, raising transaminaz and CPK blood, allergic reactions.

     The drug is contraindicated in cases of liver, gall bladder and kidney, pregnancy and breastfeeding.

     Compatible with statins (the risk rabdomioliza).

     Product : pills to 0.2 g (N. 30, 50).

Materials allowed to copy only with the active hyperlink to the handbook of medicines